Key result
Cardiac autonomic neuropathy affects ~34% of type-2 diabetes patients and tracks with cardiometabolic risk factors.
Why the study?
Cardiac autonomic neuropathy is a common but least understood and often under-diagnosed complication of diabetes leading to silent myocardial infarction and sudden death.
What is the prevalence and what are the risk factors for cardiac autonomic neuropathy in type-II diabetic patients?
Cross-Sectional (n=273)
No
What is the prevalence and what are the risk factors for cardiac autonomic neuropathy in type-II diabetic patients?
Cardiac autonomic neuropathy is highly prevalent (34%) among type-II diabetic patients and is associated with traditional cardiovascular and metabolic risk factors.
Authors
No takes yet. Share an insight, caveat, or question.
CAN prevalence estimates in T2DM are hypothesis-generating; larger prospective studies needed before guiding screening.
B.V. et al. (2021) conducted a cross-sectional in Type-II Diabetes Mellitus (n=273). Type-II Diabetes Mellitus was evaluated on Prevalence of Cardiac Autonomic Neuropathy (CAN). The prevalence of cardiac autonomic neuropathy among patients with type-II diabetes was 34%, and was significantly associated with older age, male gender, higher BMI, longer diabetes duration, poor glycemic control, hypertension, dyslipidemia, and smoking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: